Back to Search
SHARON WILCZYNSKI, MD
MD
Cytopathology Physician
NPI: 1679539407Individual
Specialties, Licenses & Credentials
Anatomic Pathology & Clinical Pathology Physician
Pathology — Anatomic Pathology & Clinical Pathology
Code: 207ZP0102X
G52867(CA)
Cytopathology PhysicianPrimary
Pathology — Cytopathology
Code: 207ZC0500X
G52867(CA)
Research & Publications (20)
Expression and mutational analysis of tyrosine kinase receptors c-kit, PDGFRalpha, and PDGFRbeta in ovarian cancers.
PMID 15791568·Hum Pathol·2005
8-other
Human papillomavirus infection as a prognostic factor in oropharyngeal squamous cell carcinomas treated in a prospective phase II clinical trial.
PMID 19443352·Anticancer Res·2009
3-trial
Impact on survival of 12 versus 3 monthly cycles of paclitaxel (175 mg/m2) administered to patients with advanced ovarian cancer who attained a complete response to primary platinum-paclitaxel: follow-up of a Southwest Oncology Group and Gynecologic Oncology Group phase 3 trial.
PMID 19447479·Gynecol Oncol·2009
3-trial
Motility induction in breast carcinoma by mammary epithelial laminin 332 (laminin 5).
PMID 19351903·Mol Cancer Res·2009
8-other
Upstream regulatory region alterations found in human papillomavirus type 16 (HPV-16) isolates from cervical carcinomas increase transcription, ori function, and HPV immortalization capacity in culture.
PMID 19458011·J Virol·2009
8-other
Phase II evaluation of neoadjuvant chemotherapy and debulking followed by intraperitoneal chemotherapy in women with stage III and IV epithelial ovarian, fallopian tube or primary peritoneal cancer: Southwest Oncology Group Study S0009.
PMID 19138791·Gynecol Oncol·2009
3-trial
Southwest Oncology Group Trial S9912: intraperitoneal cisplatin and paclitaxel plus intravenous paclitaxel and pegylated liposomal doxorubicin as primary chemotherapy of small-volume residual stage III ovarian cancer.
PMID 19464730·Gynecol Oncol·2009
3-trial
Randomized trial of pegylated liposomal doxorubicin (PLD) plus carboplatin versus carboplatin in platinum-sensitive (PS) patients with recurrent epithelial ovarian or peritoneal carcinoma after failure of initial platinum-based chemotherapy (Southwest Oncology Group Protocol S0200).
PMID 17949799·Gynecol Oncol·2008
4-observational
Inactivation of the cystatin E/M tumor suppressor gene in cervical cancer.
PMID 18506750·Genes Chromosomes Cancer·2008
8-other
Indications and efficacy of the human papillomavirus vaccine.
PMID 18172770·Curr Treat Options Oncol·2007
6-review
A phase II study of Hsp-7 (SGN-00101) in women with high-grade cervical intraepithelial neoplasia.
PMID 17631950·Gynecol Oncol·2007
3-trial
Composite recurrent hodgkin lymphoma and diffuse large B-cell lymphoma: one clone, two faces.
PMID 16891197·Am J Clin Pathol·2006
5-case
p16-Positive small cell neuroendocrine carcinoma of the endometrium.
PMID 16810063·Int J Gynecol Pathol·2006
5-case
Randomized trial of adjuvant intraperitoneal alpha-interferon in stage III ovarian cancer patients who have no evidence of disease after primary surgery and chemotherapy: An intergroup study.
PMID 16153694·Gynecol Oncol·2006
3-trial
A phase I trial of (90)Y-DOTA-anti-CEA chimeric T84.66 (cT84.66) radioimmunotherapy in patients with metastatic CEA-producing malignancies.
PMID 16706629·Cancer Biother Radiopharm·2006
3-trial
Vaccinations with recombinant variants of Aspergillus fumigatus allergen Asp f 3 protect mice against invasive aspergillosis.
PMID 16926399·Infect Immun·2006
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1500 E DUARTE RD
DUARTE, CA 91010 - Phone
- (626) 359-8111
Quick Facts
- NPI
- 1679539407
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile